Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Alpek's change in receivables for the quarter that ended in Jun. 2026 was MXN-5,139 Mil. It means Alpek's Accounts Receivable
increased by MXN5,139 Mil
from Mar. 2026 to Jun. 2026 .
Alpek's change in receivables for the fiscal year that ended in Dec. 2025 was MXN1,304 Mil. It means Alpek's Accounts Receivable
declined by MXN1,304 Mil
from Dec. 2024 to Dec. 2025 .
Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
Alpek's Days Sales Outstanding for the
three
months ended in Jun. 2026 was 41.13.
In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Alpek's liquidation value for the
three
months ended in Jun. 2026 was MXN-39,506 Mil.
Alpek (MEX:ALPEKA) Change In Receivables Explanation
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
Alpek's Days Sales Outstanding for the quarter that ended in Jun. 2026 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alpek Change In Receivables Related Terms
Alpek Change In Receivables Historical Data
* Premium members only.
The historical data trend for Alpek's Change In Receivables can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.
Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-6,020 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Change In Receivables of MXN-6,020 Mil mean?
Alpek (MEX:ALPEKA) has a Change In Receivables of MXN-6,020 Mil as of Jun. 2026. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Alpek and its competitors.
Is Alpek's Change In Receivables too high?
Alpek's current Change In Receivables is MXN-6,020 Mil. Overall, Alpek has a GF Score™ of 63/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Alpek's Change In Receivables compare to LIN and SHW?
Alpek's Change In Receivables of MXN-6,020 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Chemicals company?
A good Change In Receivables depends on the Chemicals industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Alpek and its competitors. Alpek's current Change In Receivables is MXN-6,020 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alpek stock overvalued right now?
Based on GuruFocus' analysis, Alpek (MEX:ALPEKA) is currently considered Modestly Overvalued. The stock's GF Value™ is MXN10.97, compared to a current price of MXN12.83 — trading 17% above its estimated fair value. The current Change In Receivables is MXN-6,020 Mil. Alpek's overall GF Score™ is 63/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For Alpek (MEX:ALPEKA), the current Change In Receivables is MXN-6,020 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alpek (MEX:ALPEKA) Overvalued in 2026?
Based on GuruFocus' analysis, Alpek stock appears to be overvalued.
The current stock price of MXN12.83 is trading 17% above its estimated GF Value™ of MXN10.97.
GuruFocus considers Alpek to be Modestly Overvalued.
Key valuation signals for MEX:ALPEKA:
Change In Receivables: MXN-6,020 Mil
GF Value™: MXN10.97 vs. price of MXN12.83 (17% above fair value)
No single metric tells the full story. See the MEX:ALPEKA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alpek SA is a petrochemical company with operations through two business segments: Polyester and Plastic and Chemicals. The Polyester segment comprises the production of purified terephthalic acid (PTA), polyethylene terephthalate (PET), recycled PET (rPET), and polyester fibers, which are mainly used for food and beverage packaging, textile and industrial filament markets, and The Plastics & Chemicals business segment comprises the production of polypropylene (PP), expandable styrene (EPS and Arcel), fertilizers and other chemicals, which serves a wide range of markets, including the consumer goods, automotive, construction, agriculture, pharmaceutical, and other markets. The company derives a majority of its revenue from the polyester segment.
63GF Score
Get the complete analysis for MEX:ALPEKA
Change In Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:ALPEKA has been successfully added to your 
